Credit Suisse Downgrades Sucampo Pharmaceuticals To Underperform

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Analysts at Credit Suisse downgraded

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Sucampo Pharmaceuticals, Inc.

(NASDAQ: SCMP) from Neutral to Underperform.The price target for Sucampo Pharmaceuticals has been raised from $10.00 to $13.00. Sucampo Pharmaceuticals shares have gained 81.15% over the past 52 weeks, while the S&P 500 index has surged 14.02% in the same period.Sucampo Pharmaceuticals' shares fell 3.87% to close at $15.38 on Friday.